Top News

FDA building representing regulatory review of antibody drug conjugates

INNOVATION

2 Oct 2025

Cancer’s guided missiles grow up

AbbVie, Pfizer and Merck advance antibody drug conjugates through late-stage trials and regulatory filings in a shift towards precision on...

FDA Food and Drug Administration document with stethoscope

REGULATORY

12 Feb 2026

A Faster Track for Myeloma Treatments?

TECHNOLOGY

4 Feb 2026

Why Antibody Drug Design Is Becoming an AI Problem

Latest News

INSIGHTS
30 Mar 2026
Cancer Diagnostics Haven't Kept Up with ADC Science
INNOVATION
25 Mar 2026
ADCs Have a Toxicity Problem. Dendrimers Don't.
INNOVATION
20 Mar 2026
Can a Two-Key Lock Crack Colorectal Cancer?
INSIGHTS
16 Mar 2026
Inside the High-Tech Rebirth of ADCs

New Roche Deal Targets B7H3 Tumors Worldwide

PARTNERSHIPS

10 Mar 2026

Roche secures global rights to MediLink’s YL201 ADC, expanding its oncology pipeline and deepening cross-border biotech partnerships

Molecular structure of antibody drug conjugates advancing targeted cancer care

MARKET TRENDS

10 Feb 2025

Why ADCs Are Becoming Oncology’s Most Reliable Trend

Landmark ADC deals from 2023–2024 and new 2025 approvals underscore sustained momentum in targeted cancer care

3 4

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.